Figure 3.
Clinical “stopping rules” of first and second line tyrosine kinase inhibitors. RECIST: Response Evaluation Criteria for Solid Tumors; ECOG: Eastern Cooperative Oncology Group; RECIST: Response Evaluation Criteria for Solid Tumors criteria.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.